• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Opinions
    • Top 30
    • Research
    • Supply Chain
    • Device Sectors
    • Directory
    • Events
    • Resources
    • Microsites
    • More
  • Magazine
  • News
  • Opinions
  • Top 30
  • Research
  • Supply Chain
  • Device Sectors
  • Directory
  • Events
  • Resources
  • Microsites
  • Current / Back Issues
    Features
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Reprints
    Subscribe Now
    Advertise Now
    Top Features
    Pharmaceutical Focus: A Look at Combination Products

    The Printed World: Additive Manufacturing in Medtech

    The Lost Year: 2020 Year in Review

    Extrusion Evolution

    Little Big Parts: Micromolding Under the Microscope
    OEM News
    Supplier News
    Service / Press Releases
    Online Exclusives
    Press Releases
    People in the News
    Product & Service Releases
    Supplier News
    Medtech Makers
    Technical Features
    International News
    Videos
    Product & Service Releases
    Live From Shows
    Top News
    CHF Solutions Appoints CEO

    Freehand Partners with Imperial Medial Solutions

    Intersect ENT Announces CMS Approval of Coding Application for Sinus Implant

    Hillrom to Buy Bardy Diagnostics for $375M

    Global Tissue and Organ Transplantation Market to Surpass $25.6 Billion by 2027
    From the Editor
    Blogs
    Guest Opinions
    Top Opinions
    Pharmaceutical Focus: A Look at Combination Products

    The Printed World: Additive Manufacturing in Medtech

    The Lost Year: 2020 Year in Review

    Extrusion Evolution

    Little Big Parts: Micromolding Under the Microscope
    Top 30 Medical Device Companies
    Market Data
    White Papers
    Top Research
    Fixing Face Mask Form and Function

    The Heart of the Matter: Trends in Cardiology

    Virtually the Same? The Challenges of Online Conferences

    Digital Health Delivers During a Year for the Ages

    Advanced Technology for Staking and Swaging Medical Plastics
    3D/Additive Manufacturing
    Contract Manufacturing
    Electronics
    Machining & Laser Processing
    Materials
    Molding
    Packaging & Sterilization
    R&D & Design
    Software & IT
    Testing
    Tubing & Extrusion
    Cardiovascular
    Diagnostics
    Digital Health
    Neurological
    Patient Monitoring
    Surgical
    Orthopedics
    All Companies
    Categories
    Company Capabilities
    Add New Company
    Outsourcing Directory
    FUTEK Advanced Sensor Technology Inc.

    K-Tube Technologies

    Qosina Corp.

    Creganna Medical, part of TE Connectivity

    Concise Engineering
    MPO Summit
    Industry Events
    Webinars
    Live From Show Event
    Industry Associations
    Videos
    Career Central
    eBook
    Slideshows
    Top Resources
    Meeting Critical Ventilator Product Requirements Amid Pandemic

    Impact of COVID-19 on the Medtech Supply Chain

    Finding the Upside to a Challenging Year

    Preparing Your Design Controls for FDA Approval

    A 'Trial and Error' Approach to Micromolded Parts
    Companies
    News Releases
    Product Releases
    Press Releases
    Product Spec Sheets
    Service Releases
    Case Studies
    White Papers
    Brochures
    Videos
    Outsourcing Directory
    maxon

    FUTEK Advanced Sensor Technology Inc.

    Element

    K-Tube Technologies

    MW Life Sciences
    • Magazine
      • Current/Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Editions
      • Subscribe Now
      • Advertise Now
    • News
    • Directory
      • All Companies
      • ALL CATEGORIES
      • Industry Associations
      • Company Capabilities
      • Add Your Company
    • Supply Chain
      • 3D/Additive Manufacturing
      • Contract Manufacturing
      • Electronics
      • Machining & Laser Processing
      • Materials
      • Molding
      • Packaging & Sterilization
      • R&D & Design
      • Software & IT
      • Testing
      • Tubing & Extrusion
    • Device Sectors
      • Cardiovascular
      • Diagnostics
      • Digital Health
      • Neurological
      • Patient Monitoring
      • Surgical
      • Orthopedics
    • Top 30 Company Report
    • Expert Insights
    • Slideshows
    • Videos
    • Podcasts
    • Resources
    • eBook
    • Infographics
    • Whitepapers
    • Research
      • White Papers
      • Case Studies
      • Product Spec Sheets
      • Market Data
    • MPO Summit
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Microsite
      • Companies
      • Product Releases
      • Product Spec Sheets
      • Services
      • White Papers / Tech Papers
      • Press Releases
      • Videos
      • Literature / Brochures
      • Case Studies
    • About Us
      • About Us
      • Contact Us
      • Advertise with Us
      • eNewsletter Archive
      • Privacy Policy
      • Terms of Use
    Columns

    Innovating Drug Delivery to Carry Us to the ‘New Normal’

    The growth of injectables, personalized medicine, anti-counterfeiting measures, and automation are a few trends that may follow the industry into a new normal.

    Innovating Drug Delivery to Carry Us to the ‘New Normal’
    Rahul Thakar, Ph.D., Datwyler Pharma05.01.20
    A note from the author: By the time this article runs, the team at Datwyler hopes to find the global healthcare industry and the world at large in a better position than it was in early April. As we began the month, the U.S. Surgeon General told Americans the week ahead would be the “hardest and the saddest” for many of us. Based in Philadelphia, I worry for my community. I worry for my friends, family, and colleagues near and far. And I worry for the healthcare workers on the frontline in the battle against COVID-19. This is an uncharacteristically emotional opening to a piece on drug delivery trends. Times like these remind us what is really important—not just as professionals in parenteral drug packaging operating under unprecedented circumstances—but as people who care deeply about the lives that will inevitably be turned upside-down by a once-in-a-century pandemic. This crisis will inevitably reshape many aspects of healthcare and create a new normal in ways that are hard to define right now. However, when the dust settles—and it will settle—what we can do is apply our knowledge to take the next step toward prevention, efficiency, better patient care, and hopefully, a better world.

    Before the COVID-19 outbreak earned its designation as a pandemic, a December 2019 Market Study Report projected the global drug delivery systems market would grow at a CAGR of 7.2 percent to $2.3 trillion in 2027.1 While it’s unclear what the full impact of the virus will be, we can speculate the growth will continue. It’s important to remember, however, this expansion was originally propelled by many factors, including innovations and advancements to better service patients—for which need will not disappear any time soon. The growth of injectables, personalized medicine, anti-counterfeiting measures, and automation solutions are just a few trends that may follow the industry into a new normal.

    Injectable Therapies on the Rise
    The use of injectables has grown across treatments for a wide range of chronic diseases including cardiovascular, gastrointestinal, central nervous system, respiratory, oncology, infectious disease, and urological problems. A major factor propelling the growth of injectable biologics is the increased prevalence of the chronic diseases themselves. According to the CDC, six in 10 adults in the U.S. have a chronic disease and four in 10 adults have two or more.2 Additionally, advancements in the convenience, ease of use, and reduced pain of today’s injectables have made them less daunting to patients as well as safer and more ergonomic for medical professionals who must administer them. This trend poses certain challenges, however, to the industry at large. Injectable biologics contain less stable molecules, making them more difficult to manufacture than oral medications as they are more susceptible to contamination from particulate, silicone, and protein aggregation. This added risk can be mitigated with primary packaging solutions designed around these sensitivities, such as plungers and stoppers spray coated with a no-silicone-added fluoropolymer coating to prevent contact between the drug and naked rubber. Injectable biologics are also often highly viscous, requiring unique functionality requirements on parenteral packaging components to ensure the drugs can be delivered consistently.

    Greater Personalization
    To better address unique patient needs, the healthcare industry as a whole started to shift toward value-based care. As a result, pharmaceutical companies aim to provide drug delivery methods tailored to individual patients. However, personalized medicine requires unique delivery designs and functionalities that can take pharmaceutical companies two to seven additional years to commercialize depending upon the complexity of the mechanism, as well as resources, time, and equipment. Additionally, personalized drug delivery mechanisms are manufactured in smaller quantities in line with smaller batch sizes than standard drugs, requiring flexible manufacturing practices.

    Despite the challenges that come with developing and manufacturing personalized medicine, the resulting solutions help companies better engage with patients to ensure drugs are being delivered in more effective ways. Personalized medicine also facilitates product differentiation and better brand recognition in the market, enabling drug manufacturers to better guard against ‘copy cats.’ Customized solutions such as stoppers and plungers used in prefilled syringes or autoinjectors can be designed in close collaboration between drug developers, device manufacturers, and components suppliers to ensure FDA requirements are being met while fulfilling the goal to personalize drugs and delivery methods. This collaboration implemented early in the process can help to speed time to market.

    Autoinjectors for Convenience and Differentiation
    According to an August 2019 study—Autoinjectors - Market Analysis, Trends, and Forecasts by Global Industry Analysts Inc.—the worldwide autoinjectors market is projected to grow by 22.5 percent between 2019 and 2025, with cases of rheumatoid arthritis representing a significant factor propelling that growth.3 Autoinjectors and on-body delivery devices require specialized designs for unique drug delivery needs, lifecycle management, or to improve patient experience. Increasingly, the companies that manufacture these devices seek customized solutions as to differentiate from the competition, which in turn, requires the use of customized rather than off-the shelf components. Specifying unique dimensions and functionality impacts elastomer requirements and rubber formulations. This dynamic alters the path to production, requiring the development of prototypes, testing for functionality and chemical compatibility, and further optimization based on the results. It can be a longer process to lock in the perfect design before scaling up for production, so efficiency in that process is critical. Companies ranging from the smallest biotech firms to the largest drug manufacturers, however, can find value in the differentiation. As patent cliffs approach, companies of all sizes tend to innovate and invest their intellectual capital in the drug delivery mechanism to ensure superior performance.

    Combatting Counterfeiters
    Furthermore, all drug manufacturers have a good reason to invest in highly differentiated drug delivery solutions: fighting the avalanche of counterfeit drugs. In 2019, American doctors published a piece in The American Journal of Tropical Medicine and Hygiene stating that “falsified and substandard medicines are associated with tens of thousands of deaths, mainly in young children in poor countries” and “exact an annual economic toll of up to $200 billion.4 In March, the U.S. Justice Department issued a temporary restraining order against a website marketing a fraudulent coronavirus vaccine.5 The growth of counterfeit drugs on the market can be considered its own pandemic. Aside from the necessary vigilance of the World Health Organization and government agencies around the world to identify and remove counterfeit drugs from the marketplace, companies can also combat counterfeiters through product differentiation and product education.

    Developing highly differentiated packaging for parenteral drugs with nuanced identifiers, serial numbers, barcodes, custom color components, and other design measures enhances the trackability of legitimate drugs as well as the identification properties for doctors and patients to verify the authenticity of medications.

    Enhancing Quality Control
    Injectable biologics present a higher immunogenicity risk to patients, escalating authorities’ expectations for quality control and mandating that manufacturing environments meet the more stringent regulatory and quality demands. These requirements inevitably extend to primary packaging solutions for these applications. Measures such as 100 percent camera inspection of components can minimize the accidental use of defective components. The use of vacuum sealed bags for ready-to-use components also adds a layer of security by indicating—through the absence of vacuum—if a bag may have been compromised in transport so that a drug or medical device manufacturer can reject a single compromised bag instead of rejecting the entire batch. Additionally, cellulose is a common contaminate found in medications that can be reduced by removing paper, paperboard boxes, and wooden pallets from manufacturing floors of medical devices and related components. Combined with flexible production capabilities and small-batch production, these measures boost both drug preservation and patient protection.

    Decentralizing Supply Chain Resources
    We are living in what will undoubtedly be a defining case study to support the decentralization of medical supply chains. As COVID-19 extends its toll across the world and countries implement social distancing and other sanitation and testing measures to “flatten the curve,” we see a staggered impact across the globe. As nations like China relax regional quarantine measures, others are implementing stricter restrictions to shrink the peaks in cases and deaths. Realistically, no single company has the capacity to produce billions of dose units by 2022 unless many work together.

    Collectively, companies can play a significant role in helping the world overcome this global challenge. However, scaling of production and ensuring a fluid supply of chemically compatible components requires the navigation of workforce and supply chain challenges from the lab to transportation of the final product. It takes a sophisticated supply chain network as well as plug-and-play sourcing solutions around the world to keep the operation running through all the regional obstacles to project and proactively mitigate shortfalls.

    Small Details Can Solve Big Problems
    When the world emerges from the COVID-19 pandemic, there is sure to be high-level theorizing about sweeping changes that will prevent the next crisis. However, those professionals who work closest to the actual development of medical devices and drug delivery solutions also know attention to detail drives the innovation that makes critical medications accessible and effective—from material selections to design criteria to the behind-the-scenes supply chain modifications. Drug delivery innovation is built on the details. 

    References
    1. bit.ly/mpo200521
    2. bit.ly/mpo200522
    3. bit.ly/mpo200523
    4. bit.ly/mpo200524
    5. bit.ly/mpo200525

    Rahul Thakar, Ph.D., is a technical key account manager with Datwyler, and has over 10 years of product development experience in pharmaceutical and chemical sciences. In his current role, Dr. Thakar consults with pharmaceutical and medical device companies on parenteral packaging solutions to develop safe and efficacious drug-delivery systems. He holds global responsibility for several key clients, where he is responsible for technical projects from the ideation to the commercialization stage. Within Datwyler, he is also leading strategic collaborations with external partners for product portfolio expansion and product innovation. Dr. Thakar received his B.S. in chemistry (major) and business (minor) from St. Stephens College, University of Delhi. He was awarded his Ph.D. degree in material science and analytical chemistry from Indiana University, Bloomington. His graduate research was focused on design and microfabrication of bioanalytical devices for electroanalytical measurements.

    Related Columns

    • Fixing Face Mask Form and Function

      Fixing Face Mask Form and Function

      Masks for the general public are varied in both style and effectiveness.
      Sam Brusco, Associate Editor 11.04.20

    • Cardiovascular
      The Heart of the Matter: Trends in Cardiology

      The Heart of the Matter: Trends in Cardiology

      Of the three major segments of coronary stents, bioabsorbable stents are expected to have the highest growth between now and 2022.
      Maria Shepherd, President and Founder, Medi-Vantage 11.04.20

    • Virtually the Same? The Challenges of Online Conferences

      Virtually the Same? The Challenges of Online Conferences

      Like everyone else on the planet, I’m turning increasingly to virtual solutions to our physical challenges in the midst of a pandemic.
      Dawn A. Lissy, Founder & President, Empirical 11.04.20


    • Digital Health
      Digital Health Delivers During a Year for the Ages

      Digital Health Delivers During a Year for the Ages

      Internet of Medical Things technologies have emerged as the key enabler of a much more holistic and complete disease-state management toolbox.
      Brad Womble, Senior Director of Strategy, Marketing, and Mergers & Acquisitions, Jabil Healthcare 11.04.20

    • Advanced Technology for Staking and Swaging Medical Plastics

      Advanced Technology for Staking and Swaging Medical Plastics

      It reliably assembles heat- and vibration-sensitive components, and works with a wide range of plastic materials.
      Priyank Kishor, Global Product Manager—PulseStaking, Branson at Emerson 11.04.20

    • Quality Assurance When Supply Chain Disruptions Arise

      Quality Assurance When Supply Chain Disruptions Arise

      From supply chain disruptions to impromptu manufacturing modifications, the medical device industry has faced a whirlwind of complications in 2020.
      Sandi Schaible and Peter Steen, WuXi AppTec Medical Device Testing 11.04.20


    • The Top 30 and M&A in 2021: What’s Next?

      The Top 30 and M&A in 2021: What’s Next?

      With three of the top five companies appointing new CEOs in the last year and the global pandemic eroding earnings, M&A strategies could look a lot different.
      Florence Joffroy-Black and Dave Sheppard, MedWorld Advisors 11.04.20

    • COVID 19: Supply Chain Professionals’ Ultimate Reality Challenge

      COVID 19: Supply Chain Professionals’ Ultimate Reality Challenge

      Having been a part of the medtech supply chain for 40 years, I can say there has never been a more difficult time for supply chain professionals.
      Chris Oleksy, Founder and CEO, Oleksy Enterprises and Next Life Medical; CEO, Emergent Respiratory 11.04.20

    • Congress Examines Additional COVID-19 Relief and Recent Regulatory Changes

      Congress Examines Additional COVID-19 Relief and Recent Regulatory Changes

      The legislative year is nearly coming to a close as Washington survives yet another tumultuous election cycle.
      Jeffrey J. Kimbell, Eric P. Juhl, JD and David C. Rudloff, Jeffrey J. Kimbell & Associates Inc. 11.04.20


    • 3D/Additive Manufacturing
      Additive Manufacturing: Debinding Fluids Must-Haves

      Additive Manufacturing: Debinding Fluids Must-Haves

      As the pressure to produce more complex biomedical parts increases, medical device manufacturing using 3D printing is gaining widespread acceptance.
      Venesia Hurtubise, Technical Chemist, MicroCare Medical 11.04.20

    • Diagnostics
       How COVID-19 is Reshaping the Diagnostics Testing Sector

      How COVID-19 is Reshaping the Diagnostics Testing Sector

      The short-term impact on the diagnostics sector is readily apparent as the pandemic has fueled overwhelming demand for effective SARS-CoV-2 testing solutions.
      Eric Williams, Managing Director, Capstone Headwaters 11.04.20

    • Will Industry’s COVID-19 Recovery End Prematurely?

      Will Industry’s COVID-19 Recovery End Prematurely?

      Finally, a light at the end of the tunnel, but will it remain lit?
      Michael Barbella, Managing Editor 10.01.20


    • Surgical
      Hype or Hope? The Future of Surgical Robotics

      Hype or Hope? The Future of Surgical Robotics

      Recent publications suggest the U.S. performs more robotic surgery than every other country in the world.
      Maria Shepherd, President and Founder, Medi-Vantage 10.01.20

    • COVID Community: How the Pandemic Is Bringing Out the Best in Us

      COVID Community: How the Pandemic Is Bringing Out the Best in Us

      Given the brain power and generosity of our industry, I knew I could follow the wisdom of Fred Rogers’ mother and “look for the helpers.”
      Dawn A. Lissy, Founder & President, Empirical 10.01.20

    • Electronics
      Why Applying Cleanliness Standards to Outsourced Medical Electronics Is Important

      Why Applying Cleanliness Standards to Outsourced Medical Electronics Is Important

      When looking to outsource the manufacture of electronic medical devices, cleanliness standards and processes should be a top consideration.
      Jay Tourigny, Senior Vice President, MicroCare Medical 10.01.20


    Trending
    • Philips Buys Capsule Technologies In $635M Deal
    • Cytotron Gains Breakthrough Status To Treat Breast, Liver, And Pancreatic Cancers
    • Top 10 Trends In The Medical Device And Equipment Industry
    • 5 Ways Plastics Revolutionized The Healthcare Industry
    • Hillrom To Buy Bardy Diagnostics For $375M
    Breaking News
    • CHF Solutions Appoints CEO
    • Freehand Partners with Imperial Medial Solutions
    • Intersect ENT Announces CMS Approval of Coding Application for Sinus Implant
    • Hillrom to Buy Bardy Diagnostics for $375M
    • Global Tissue and Organ Transplantation Market to Surpass $25.6 Billion by 2027
    View Breaking News >
    CURRENT ISSUE

    November/December 2020

    • Pharmaceutical Focus: A Look at Combination Products
    • The Printed World: Additive Manufacturing in Medtech
    • The Lost Year: 2020 Year in Review
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    BGG Obtains U.S. Patent on AstaZine Natural Astaxanthin for Heart Function During Exercise
    Qualitas Health/iwi Raises $10 Million in Investment Round
    Aker BioMarine Expands Krill Portfolio with Novel Protein Hydrolysate
    Coatings World

    Latest Breaking News From Coatings World

    IGL Coatings Launches Graphene Reinforced Dual System Ceramic Coating
    Miller Paint Declares Simple Serenity its 2021 Color of the Year
    TAUBMANS Paint by PPG Releases ‘Chromatic Joy’ Palettes
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    CHF Solutions Appoints CEO
    Freehand Partners with Imperial Medial Solutions
    Intersect ENT Announces CMS Approval of Coding Application for Sinus Implant
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Bone Therapeutics, Rigenerand Ink Cell Therapy Deal
    NovaQuest Private Equity Acquires CoreRx
    JS Bio and Etta Biotech Advancing Partnership
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Marino Belotti Presents New Website
    Essence Cosmetics Expands in the U.S.
    Sigma Beauty Launches 'Brush Care' Sets at Sephora
    Happi

    Latest Breaking News From Happi

    Mix:Bar Launches at Target
    Crystal Deodorant Unveils Magnesium-Enriched Sticks
    Euromonitor Reveals Top 10 Global Consumer Trends for 2021
    Ink World

    Latest Breaking News From Ink World

    Cowan Graphics Adds Fujifilm Inca OnsetX3 HS
    Packaging Printing Market Worth $433.4 Billion by 2025: MarketsandMarkets
    O-I Foundation Gifts $50k to Facilitate COVID-19 Vaccine Access
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Domino grows installation and service teams
    ABG keeps pace with demand with recruitment drive
    Acucote expands FSC-certified portfolio
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Honeywell Delivered 225 Million Masks in December
    Techtextil, Texprocess Postponed to 2022
    Super Strong Inks Survive Tough Environments
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Bioventus Appoints SVP of Operations
    DePuy Synthes Receives 510(k) FDA Clearance for VELYS Robotic-Assisted Solution
    OrthoPediatrics Expands Agent Network in Three European Countries
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    UDC Subsidiary Adesis' Website Wins 2020 MarCom Platinum Award
    Roadsimple Modernizes Warehouse Ops with Zebra Technologies
    Graphene Flagship Launches Redesigned Website

    Copyright © 2021 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login